Europe Must Act To Fix Vulnerable Nuclear Medicine Supply Chain, Says ENS High Scientific Council
Production of many medical radioisotopes takes place in research reactors, which are experiencing ageing issues
Production of many medical radioisotopes takes place in research reactors, which are experiencing ageing issues
Brussels-based ENS advisory group says existing reactors are ‘strategic asset’ for bloc
Guests highlight ‘critical role’ in shaping the future of the industry.
Group also calls for accelerated research and development, and better investment conditions
Meeting will feature exclusive technical tour of International Thermonuclear Experimental Reactor nuclear fusion site
Register free and get full access to NucNet for 14 days. No card required.
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options